Global CAR T-Cell Therapy Competitive Landscape Professional Research Report 2025
Description
Global CAR T-Cell Therapy Competitive Landscape Professional Research Report 2025
Research Summary
CAR T-cell therapy, also known as chimeric antigen receptor T-cell therapy, is an innovative and personalized immunotherapy approach used in the treatment of certain types of cancer. It involves modifying a patient＇s own T cells, which are a type of immune cell, to express a synthetic receptor called a chimeric antigen receptor (CAR) on their surface. The CAR is designed to recognize and bind to specific proteins, known as antigens, found on cancer cells. Once the modified CAR T cells are infused back into the patient＇s body, they can identify and attack cancer cells that express the targeted antigen, effectively destroying the cancer cells. CAR T-cell therapy has shown remarkable success in the treatment of certain hematological malignancies, such as acute lymphoblastic leukemia (ALL) and certain types of non-Hodgkin lymphoma. It has provided new hope for patients who have exhausted other treatment options, and its efficacy continues to be investigated in clinical trials for various other types of cancers. CAR T-cell therapy represents a promising advancement in cancer treatment, harnessing the power of the patient＇s own immune system to fight and potentially eradicate cancer cells.
According to DIResearch's in-depth investigation and research, the global CAR T-Cell Therapy market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of CAR T-Cell Therapy include Bristol Myers Squibb, Gilead Sciences, Novartis, Autolus, Janssen, JW Therapeutics, Beijing Immunochina Pharmaceuticals, Bioray Laboratories etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of CAR T-Cell Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global CAR T-Cell Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the CAR T-Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CAR T-Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of CAR T-Cell Therapy Include:
Bristol Myers Squibb
Gilead Sciences
Novartis
Autolus
Janssen
JW Therapeutics
Beijing Immunochina Pharmaceuticals
Bioray Laboratories
CAR T-Cell Therapy Product Segment Include:
CD19
BCMA
CD19/CD22
Others
CAR T-Cell Therapy Product Application Include:
Non-Hodgkin Lymphoma
Multiple Myeloma
Acute Lymphoblastic Leukemia
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global CAR T-Cell Therapy Industry PESTEL Analysis
Chapter 3: Global CAR T-Cell Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global CAR T-Cell Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global CAR T-Cell Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global CAR T-Cell Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 CAR T-Cell Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 CAR T-Cell Therapy Product by Type
- 1.2.1 CD19
- 1.2.2 BCMA
- 1.2.3 CD19/CD22
- 1.2.4 Others
- 1.3 CAR T-Cell Therapy Product by Application
- 1.3.1 Non-Hodgkin Lymphoma
- 1.3.2 Multiple Myeloma
- 1.3.3 Acute Lymphoblastic Leukemia
- 1.3.4 Other
- 1.4 Global CAR T-Cell Therapy Market Size Analysis (2020-2032)
- 1.5 CAR T-Cell Therapy Market Development Status and Trends
- 1.5.1 CAR T-Cell Therapy Industry Development Status Analysis
- 1.5.2 CAR T-Cell Therapy Industry Development Trends Analysis
- 2 CAR T-Cell Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 CAR T-Cell Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global CAR T-Cell Therapy Market Analysis by Regions
- 4.1 CAR T-Cell Therapy Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global CAR T-Cell Therapy Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global CAR T-Cell Therapy Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global CAR T-Cell Therapy Revenue Forecast by Region (2026-2032)
- 5 Global CAR T-Cell Therapy Market Size by Type and Application
- 5.1 Global CAR T-Cell Therapy Market Size by Type (2020-2032)
- 5.2 Global CAR T-Cell Therapy Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America CAR T-Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America CAR T-Cell Therapy Market Size by Type
- 6.4 North America CAR T-Cell Therapy Market Size by Application
- 6.5 North America CAR T-Cell Therapy Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe CAR T-Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe CAR T-Cell Therapy Market Size by Type
- 7.4 Europe CAR T-Cell Therapy Market Size by Application
- 7.5 Europe CAR T-Cell Therapy Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China CAR T-Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China CAR T-Cell Therapy Market Size by Type
- 8.4 China CAR T-Cell Therapy Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) CAR T-Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) CAR T-Cell Therapy Market Size by Type
- 9.4 APAC (excl. China) CAR T-Cell Therapy Market Size by Application
- 9.5 APAC (excl. China) CAR T-Cell Therapy Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America CAR T-Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America CAR T-Cell Therapy Market Size by Type
- 10.4 Latin America CAR T-Cell Therapy Market Size by Application
- 10.5 Latin America CAR T-Cell Therapy Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa CAR T-Cell Therapy Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa CAR T-Cell Therapy Market Size by Type
- 11.4 Middle East & Africa CAR T-Cell Therapy Market Size by Application
- 11.5 Middle East & Africa CAR T-Cell Therapy Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global CAR T-Cell Therapy Market Revenue by Key Manufacturers (2021-2025)
- 12.2 CAR T-Cell Therapy Competitive Landscape Analysis and Market Dynamic
- 12.2.1 CAR T-Cell Therapy Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Bristol Myers Squibb
- 13.1.1 Bristol Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Bristol Myers Squibb CAR T-Cell Therapy Product Portfolio
- 13.1.3 Bristol Myers Squibb CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Gilead Sciences
- 13.2.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Gilead Sciences CAR T-Cell Therapy Product Portfolio
- 13.2.3 Gilead Sciences CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Novartis
- 13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Novartis CAR T-Cell Therapy Product Portfolio
- 13.3.3 Novartis CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Autolus
- 13.4.1 Autolus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Autolus CAR T-Cell Therapy Product Portfolio
- 13.4.3 Autolus CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Janssen
- 13.5.1 Janssen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Janssen CAR T-Cell Therapy Product Portfolio
- 13.5.3 Janssen CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 JW Therapeutics
- 13.6.1 JW Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 JW Therapeutics CAR T-Cell Therapy Product Portfolio
- 13.6.3 JW Therapeutics CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Beijing Immunochina Pharmaceuticals
- 13.7.1 Beijing Immunochina Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Beijing Immunochina Pharmaceuticals CAR T-Cell Therapy Product Portfolio
- 13.7.3 Beijing Immunochina Pharmaceuticals CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Bioray Laboratories
- 13.8.1 Bioray Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Bioray Laboratories CAR T-Cell Therapy Product Portfolio
- 13.8.3 Bioray Laboratories CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 CAR T-Cell Therapy Industry Chain Analysis
- 14.2 CAR T-Cell Therapy Industry Raw Material and Suppliers Analysis
- 14.2.1 CAR T-Cell Therapy Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 CAR T-Cell Therapy Typical Downstream Customers
- 14.4 CAR T-Cell Therapy Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
